Context Rapid developments in e-cigarettes, or electronic nicotine delivery systems (ENDS),
and the evolution of the overall tobacco product marketplace warrant frequent evaluation of …

Background Cigarette smoking is one of the leading causes of early death. Varenicline
[Champix (UK), Pfizer Europe MA EEIG, Brussels, Belgium; or Chantix (USA), Pfizer Inc …

Among adolescents, low socioeconomic status (SES) is associated with greater exposure to
tobacco cigarette advertising and cigarette use. However, associations among SES, e …

A consistent approach using standardised items to assess e-cigarette use in both youth and
adult populations will aid cross-survey and cross-national comparisons of the effect of e …

Abstract Introduction Many European Union (EU) Member States have expressed the need
for EU legislation to clarify the issue of e-cigarette taxation, but the economic evidence to …

Introduction In the last 5 years, there has been a dramatic shift in the types of nicotine
products being purchased. This study aimed to estimate how much users spend on types of …

Abstract Background and Aims Nicotine vaping products (NVPs) can potentially help adult
tobacco users quit smoking. This study evaluated how adult consumers compare the costs …

Whilst e-cigarettes have been characterised by Public Health England as being around 95%
less harmful than combustible tobacco products, only a minority of current smokers (around …

Tobacco use in high-income countries correlates with socio-economic disadvantage, but
although switching to electronic cigarettes could be a safer alternative, little is known about …

Study objectives To compare the prices paid for nicotine vaping products (NVPs) and
supplies among current NVP users to prices paid for cigarettes among current smokers …